Model* | Odds ratio | 95% CI |
---|---|---|
Positive predictive value for atrophic gastritis | ||
 Model 1 | ||
  Test 1 vs. Test 2 | 1.00 | 0.42–2.38 |
 Model 2 | ||
  Test 1 vs. Test 2 | 1.12 | 0.40–3.12 |
  Age ≥ 50 vs. 30–49 years | 3.68 | 0.67–20.16 |
  Male vs. female | 1.11 | 0.34–3.61 |
Positive predictive value for intestinal metaplasia | ||
 Model 1 | ||
  Test 1 vs. Test 2 | 1.16 | 0.54–2.48 |
 Model 2 | ||
  Test 1 vs. Test 2 | 1.75 | 0.65–4.67 |
  Age ≥ 50 vs. 30–49 years | 5.97 | 1.12–31.77†|
  Male vs. female | 2.84 | 0.94–8.55 |
Detection rate for atrophic gastritis | ||
 Model 1 | ||
  Test 1 vs. Test 2 | 1.00 | 0.45–2.23 |
 Model 2 | ||
  Test 1 vs. Test 2 | 1.00 | 0.45–2.24 |
  Age ≥ 50 vs. 30–49 years | 5.61 | 1.30–24.15†|
  Male vs. female | 1.37 | 0.58–3.25 |
Detection rate for intestinal metaplasia | ||
 Model 1 | ||
  Test 1 vs. Test 2 | 1.13 | 0.57–2.21 |
 Model 2 | ||
  Test 1 vs. Test 2 | 1.20 | 0.60–2.40 |
  Age ≥ 50 vs. 30–49 years | 8.91 | 2.12–37.51†|
  Male vs. female | 2.23 | 1.01–4.96†|